Stay updated on CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Sign up to get notified when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.
Latest website image capture
Clouds background image

Latest updates to the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    - Added a prominent funding/status notice and updated to revision v3.2.0. - Removed the previous revision reference v3.1.0.
    Difference
    3%
    Check dated 2025-10-07T23:20:16.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Overall, the page updates to a new revision (v3.1.0) with added contact details and identifiers; the previous revision v3.0.2 was removed.
    Difference
    0.1%
    Check dated 2025-09-30T02:40:42.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Page version updated from v3.0.1 to v3.0.2; no substantive content changes detected; the 'Back to Top' control was removed as a minor UI adjustment.
    Difference
    0.2%
    Check dated 2025-09-15T19:22:23.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-08T14:59:03.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility and location information, as well as additional topics related to colorectal cancer and gastrointestinal diseases. Notably, specific drug names such as cabozantinib, durvalumab, and tremelimumab have been added.
    Difference
    3%
    Check dated 2025-09-01T09:38:13.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-18T02:15:55.000Z thumbnail image

Stay in the know with updates to CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Enter your email address, and we'll notify you when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.